Ipsen SA (IPN) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.125x

Based on the latest financial reports, Ipsen SA (IPN) has a cash flow conversion efficiency ratio of 0.125x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€526.70 Million ≈ $615.77 Million USD) by net assets (€4.23 Billion ≈ $4.95 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Ipsen SA - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Ipsen SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Ipsen SA (IPN) financial obligations for a breakdown of total debt and financial obligations.

Ipsen SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ipsen SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Aramark Holdings NYSE:ARMK	-0.242x
Skanska AB (publ) ST:SKA-B	0.061x
RAKUTEN GROUP SPONS.ADR 1 F:RAKA	N/A
The Clorox Company NYSE:CLX	8.886x
Trade Desk Inc NASDAQ:TTD	0.125x
Yangzijiang Shipbuilding (Holdings) Ltd F:B8O	0.034x
Texas Roadhouse Inc NASDAQ:TXRH	0.097x
Itaúsa - Investimentos Itaú SA SA:ITSA3	-0.002x

Annual Cash Flow Conversion Efficiency for Ipsen SA (2002–2024)

The table below shows the annual cash flow conversion efficiency of Ipsen SA from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Ipsen SA.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€4.18 Billion ≈ $4.89 Billion	€915.50 Million ≈ $1.07 Billion	0.219x	-3.32%
2023-12-31	€3.82 Billion ≈ $4.47 Billion	€865.90 Million ≈ $1.01 Billion	0.226x	-22.22%
2022-12-31	€3.34 Billion ≈ $3.90 Billion	€971.40 Million ≈ $1.14 Billion	0.291x	-12.34%
2021-12-31	€2.74 Billion ≈ $3.20 Billion	€909.20 Million ≈ $1.06 Billion	0.332x	-8.12%
2020-12-31	€2.13 Billion ≈ $2.49 Billion	€771.30 Million ≈ $901.73 Million	0.361x	+0.94%
2019-12-31	€1.75 Billion ≈ $2.05 Billion	€627.70 Million ≈ $733.85 Million	0.358x	+15.62%
2018-12-31	€1.84 Billion ≈ $2.16 Billion	€570.90 Million ≈ $667.44 Million	0.310x	+12.48%
2017-12-31	€1.54 Billion ≈ $1.80 Billion	€422.90 Million ≈ $494.41 Million	0.275x	+18.02%
2016-12-31	€1.36 Billion ≈ $1.59 Billion	€317.80 Million ≈ $371.54 Million	0.233x	+27.88%
2015-12-31	€1.23 Billion ≈ $1.43 Billion	€223.60 Million ≈ $261.41 Million	0.182x	-20.74%
2014-12-31	€1.07 Billion ≈ $1.25 Billion	€245.80 Million ≈ $287.37 Million	0.230x	+19.15%
2013-12-31	€973.70 Million ≈ $1.14 Billion	€188.10 Million ≈ $219.91 Million	0.193x	+24.07%
2012-12-31	€926.25 Million ≈ $1.08 Billion	€144.22 Million ≈ $168.61 Million	0.156x	-9.89%
2011-12-31	€1.02 Billion ≈ $1.19 Billion	€175.45 Million ≈ $205.11 Million	0.173x	-26.56%
2010-12-31	€1.08 Billion ≈ $1.26 Billion	€253.91 Million ≈ $296.85 Million	0.235x	-10.11%
2009-12-31	€984.35 Million ≈ $1.15 Billion	€257.62 Million ≈ $301.19 Million	0.262x	+11.75%
2008-12-31	€868.49 Million ≈ $1.02 Billion	€203.41 Million ≈ $237.81 Million	0.234x	+6.63%
2007-12-31	€801.11 Million ≈ $936.58 Million	€175.97 Million ≈ $205.73 Million	0.220x	-51.20%
2006-12-31	€727.90 Million ≈ $851.00 Million	€327.63 Million ≈ $383.04 Million	0.450x	+86.93%
2005-12-31	€621.10 Million ≈ $726.13 Million	€149.55 Million ≈ $174.84 Million	0.241x	-44.79%
2004-12-31	€197.73 Million ≈ $231.17 Million	€86.23 Million ≈ $100.82 Million	0.436x	-10.31%
2003-12-31	€311.65 Million ≈ $364.36 Million	€151.54 Million ≈ $177.17 Million	0.486x	+18.78%
2002-12-31	€227.95 Million ≈ $266.50 Million	€93.32 Million ≈ $109.10 Million	0.409x	--

About Ipsen SA

PA:IPN France Drug Manufacturers - Specialty & Generic

Market Cap

$16.09 Billion

€13.76 Billion EUR

Market Cap Rank

#2159 Global

#45 in France

Share Price

€167.00

Change (1 day)

+2.52%

52-Week Range

€100.60 - €170.80

All Time High

€170.80